As of 2025-10-18, the Relative Valuation of Atea Pharmaceuticals Inc (AVIR) is (35.94) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.06 USD, the upside of Atea Pharmaceuticals Inc based on Relative Valuation is -1274.4%.
The range of the Relative Valuation is (31.90) - (35.99) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.2x - 21.0x | 20.5x |
| Forward P/E multiples | 18.6x - 23.3x | 21.4x |
| Fair Price | (31.90) - (35.99) | (35.94) |
| Upside | -1142.6% - -1276.1% | -1274.4% |
| Date | P/E |
| 2025-10-16 | -1.82 |
| 2025-10-15 | -1.84 |
| 2025-10-14 | -1.83 |
| 2025-10-13 | -1.81 |
| 2025-10-10 | -1.83 |
| 2025-10-09 | -1.82 |
| 2025-10-08 | -1.81 |
| 2025-10-07 | -1.73 |
| 2025-10-06 | -1.70 |
| 2025-10-03 | -1.69 |
| 2025-10-02 | -1.64 |
| 2025-10-01 | -1.68 |
| 2025-09-30 | -1.69 |
| 2025-09-29 | -1.70 |
| 2025-09-26 | -1.71 |
| 2025-09-25 | -1.70 |
| 2025-09-24 | -1.69 |
| 2025-09-23 | -1.69 |
| 2025-09-22 | -1.71 |
| 2025-09-19 | -1.68 |
| 2025-09-18 | -1.73 |
| 2025-09-17 | -1.70 |
| 2025-09-16 | -1.73 |
| 2025-09-15 | -1.77 |
| 2025-09-12 | -1.83 |
| 2025-09-11 | -1.92 |
| 2025-09-10 | -1.84 |
| 2025-09-09 | -1.84 |
| 2025-09-08 | -1.89 |
| 2025-09-05 | -1.96 |
| 2025-09-04 | -1.94 |
| 2025-09-03 | -2.02 |
| 2025-09-02 | -1.98 |
| 2025-08-29 | -1.96 |
| 2025-08-28 | -2.02 |
| 2025-08-27 | -2.10 |
| 2025-08-26 | -2.13 |
| 2025-08-25 | -2.13 |
| 2025-08-22 | -2.13 |
| 2025-08-21 | -2.06 |
| 2025-08-20 | -2.04 |
| 2025-08-19 | -2.03 |
| 2025-08-18 | -2.06 |
| 2025-08-15 | -2.04 |
| 2025-08-14 | -2.03 |
| 2025-08-13 | -2.04 |
| 2025-08-12 | -2.05 |
| 2025-08-11 | -2.05 |
| 2025-08-08 | -1.97 |
| 2025-08-07 | -2.02 |